SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001144204-16-080944
Filing Date
2016-02-11
Accepted
2016-02-11 17:24:38
Documents
2
Group Members
H. GEORGE SCHULERRENATE SCHULERSCHULER FAMILY FOUNDATIONTANYA EVA SCHULER TRUSTTHERESE HEIDI SCHULER TRUSTTINO HANS SCHULER TRUST

Document Format Files

Seq Description Document Type Size
1 SC 13D/A v431482_sc13da.htm SC 13D/A 168752
2 EXHIBIT 1 v431482_ex-1.htm EX-99.1 9818
  Complete submission text file 0001144204-16-080944.txt   180059
Mailing Address 100 N. FIELD DRIVE SUITE 360 LAKE FOREST IL 60045
Business Address
SCHULER JACK W (Filed by) CIK: 0001021412 (see all company filings)

Type: SC 13D/A

Mailing Address 101 COLLEGE STREET SUITE 220 TORONTO A6 M5G 1L7
Business Address 101 COLLEGE STREET SUITE 220 TORONTO A6 M5G 1L7 416-260-7770
Transition Therapeutics Inc. (Subject) CIK: 0001399250 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 0630
Type: SC 13D/A | Act: 34 | File No.: 005-83093 | Film No.: 161412862
SIC: 2833 Medicinal Chemicals & Botanical Products